van Det N F, van den Born J, Tamsma J T, Verhagen N A, Berden J H, Bruijn J A, Daha M R, van der Woude F J
Department of Nephrology, University Hospital Leiden, The Netherlands.
Kidney Int. 1996 Apr;49(4):1079-89. doi: 10.1038/ki.1996.157.
Changes in heparan sulfate metabolism may be important in the pathogenesis of diabetic nephropathy. Recent studies performed on renal biopsies from patients with diabetic nephropathy revealed a decrease in heparan sulfate glycosaminoglycan staining in the glomerular basement membrane without changes in staining for heparan sulfate proteoglycan-core protein. To understand this phenomenon at the cellular level, we investigated the effect of high glucose conditions on the synthesis of heparan sulfate proteoglycan by glomerular cells in vitro. Human adult mesangial and glomerular visceral epithelial cells were cultured under normal (5 mM) and high glucose (25 mM) conditions. Immunofluorescence performed on cells cultured in 25 mM glucose confirmed and extended the in vivo histological observations. Using metabolic labeling we observed an altered proteoglycan production under high glucose conditions, with predominantly a decrease in heparan sulfate compared to dermatan sulfate or chondroitin sulfate proteoglycan. N-sulfation analysis of heparan sulfate proteoglycan produced under high glucose conditions revealed less di- and tetrasaccharides compared to larger oligosaccharides, indicating an altered sulfation pattern. Furthermore, with quantification of glomerular basement membrane heparan sulfate by ELISA, a significant decrease was observed when mesangial and visceral epithelial cells were cultured in high glucose conditions. We conclude that high glucose concentration induces a significant alteration of heparan sulfate production by mesangial cells and visceral epithelial cells. Changes in sulfation and changes in absolute quantities are both observed and may explain the earlier in vivo observations. These changes may be of importance for the altered integrity of the glomerular charge-dependent filtration barrier and growth-factor matrix interactions in diabetic nephropathy.
硫酸乙酰肝素代谢的变化可能在糖尿病肾病的发病机制中起重要作用。最近对糖尿病肾病患者肾活检组织进行的研究显示,肾小球基底膜中硫酸乙酰肝素糖胺聚糖染色减少,而硫酸乙酰肝素蛋白聚糖核心蛋白的染色没有变化。为了在细胞水平上理解这一现象,我们在体外研究了高糖条件对肾小球细胞硫酸乙酰肝素蛋白聚糖合成的影响。将成人人类系膜细胞和肾小球脏层上皮细胞在正常(5 mM)和高糖(25 mM)条件下培养。对在25 mM葡萄糖中培养的细胞进行免疫荧光检测,证实并扩展了体内组织学观察结果。使用代谢标记法,我们观察到在高糖条件下蛋白聚糖产生发生改变,与硫酸皮肤素或硫酸软骨素蛋白聚糖相比,硫酸乙酰肝素主要减少。对高糖条件下产生的硫酸乙酰肝素蛋白聚糖进行N-硫酸化分析发现,与较大的寡糖相比,二糖和四糖较少,表明硫酸化模式改变。此外,通过ELISA对肾小球基底膜硫酸乙酰肝素进行定量分析,当系膜细胞和脏层上皮细胞在高糖条件下培养时,观察到显著减少。我们得出结论,高糖浓度会诱导系膜细胞和脏层上皮细胞硫酸乙酰肝素产生显著改变。观察到了硫酸化变化和绝对量变化,这可能解释了早期的体内观察结果。这些变化可能对糖尿病肾病中肾小球电荷依赖性滤过屏障的完整性改变和生长因子-基质相互作用具有重要意义。